EyeYon Medical was proud to participate in the 43rd Congress of the European Society of Cataract and Refractive Surgeons (ESCRS), held in Copenhagen.
Our team and collaborators took an active role throughout the event – leading instructional courses, delivering scientific presentations, participating in the Ophthalmology Futures Forum, and sharing clinical insights through ePosters and live demonstrations.
Highlights from Our Participation
EndoArt® – Transforming Corneal Care
Our experts presented the latest advances in EndoArt®, showcasing its role as a novel, tissue-free solution for patients with complex corneal conditions and high-risk endothelial failure.
Speakers included David Lockington, Sorcha Ní Dhubhghaill, Luis Fernández-Vega Cueto, Alain Saad, Romesh Angunawela, Björn Bachmann, Ofer Daphna, Arie Marcovich, Itay Lavy, and Thomas Poole.
Hyper-CL Innovation
Results from a randomized controlled study demonstrated how the Hyper-CL drug-depository lens can reduce antimicrobial treatment burden in bacterial keratitis, presented by Lionel Raj Daniel Ponniah.
Scientific & Clinical Impact
Our presentations covered a wide range of topics – from long-term outcomes and one-year follow-up of EndoArt® implantation, to comparisons of artificial endothelial devices versus human tissue – reflecting EyeYon’s leadership in advancing corneal therapeutics.
Thought Leadership
At the Ophthalmology Futures Forum, Nahum Ferera, CEO of EyeYon Medical, shared his perspectives on how device- and cell-based therapies can together shape the future of corneal disease treatment, highlighting EyeYon’s innovative vision for regenerative ophthalmology.
Collaborative Research
EyeYon’s commitment to clinical excellence was further represented in multiple ePosters on corneal surgery and endothelial keratoplasty, presented by Irit Levy, Ruth Lapid, Christophe Panthier, Elad Karasati, Armin Motaabbed, Victor Augustin, Nadav Karawani, and Savithri Sreekala.
We were honored to share our progress and vision with the global ophthalmology community and look forward to continuing to redefine the future of corneal care.
A heartfelt thank you to all our presenters, collaborators, and partners for making this event such a success!
See the original post and join the conversation on LinkedIn:
https://www.linkedin.com/posts/eyeyon-medical_escrs2025-ophthalmology-cornealdisease-activity-7370800328876924928-4zMw
